MEZGEBE ABEGAZ
Allopathic & Osteopathic Physicians|Physical Medicine & Rehabilitation CROWN POINT, IN NPI 1821402769
Browse related groups: Allopathic & Osteopathic Physicians|Physical Medicine & Rehabilitation IN Allergan Inc. All categories
General Payments — all program years on this page
$545.27
- Category: General Payments
- Program years: PY2019
- Record count: 9
- As of (CMS publication): 2026-01-23
Latest program year (PY2019): $545.27 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2019) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $545.27 | 9 |
By paying entity
Latest program year (PY2019) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Allergan Inc. | $292.22 | 5 |
| Avanir Pharmaceuticals, Inc. | $170.78 | 3 |
| Janssen Pharmaceuticals, Inc | $82.27 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2019 | $545.27 | 9 |
Records — PY2019 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 653617441 | Avanir Pharmaceuticals, Inc. | $23.15 | 04/17/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 653617443 | Avanir Pharmaceuticals, Inc. | $130.14 | 03/14/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 653617445 | Avanir Pharmaceuticals, Inc. | $17.49 | 02/27/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 658246773 | Janssen Pharmaceuticals, Inc | $82.27 | 04/04/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 669997575 | Allergan Inc. | $143.80 | 02/20/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 669997577 | Allergan Inc. | $16.17 | 07/09/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 669997579 | Allergan Inc. | $95.25 | 10/23/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 669997581 | Allergan Inc. | $20.70 | 11/22/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 669997583 | Allergan Inc. | $16.30 | 12/12/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.